AA
DXCM icon

Altman Advisors’s DexCom DXCM Stock Holding History

Altman Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-13,950
Closed -$1.92M – 77
2024
Q1 		$1.92M Buy
13,950
+376
+3% +$47.3K 0.94% 35
2023
Q4 		$1.68M Buy
13,574
+264
+2% +$27K 0.88% 37
2023
Q3 		$1.24M Buy
+13,310
New +$1.5M 0.78% 69
2023
Q1 		$1.35M Buy
13,237
+242
+2% +$27.1K 1.24% 27
2022
Q4 		$1.38M Sell
12,995
-961
-7% -$106K 0.85% 45
2022
Q3 		$1.12M Buy
13,956
+418
+3% +$35.4K 0.71% 56
2022
Q2 		$1.2M Buy
13,538
+106
+0.8% +$9.67K 0.68% 69
2022
Q1 		$1.72M Sell
13,432
-8,792
-40% -$962K 0.89% 35
2021
Q4 		$2.35M Buy
22,224
+548
+3% +$78.7K 1.43% 30
2021
Q3 		$3.38M Buy
21,676
+164
+0.8% +$20.7K 1.87% 15
2021
Q2 		$2.78M Buy
21,512
+1,284
+6% +$123K 1.57% 21
2021
Q1 		$1.82M Sell
20,228
-1,104
-5% -$104K 1.17% 39
2020
Q4 		$1.97M Buy
21,332
+360
+2% +$32.1K 1.24% 37
2020
Q3 		$2.16M Buy
20,972
+448
+2% +$46.8K 1.53% 27
2020
Q2 		$2.08M Buy
20,524
+4,328
+27% +$387K 1.77% 25
2020
Q1 		$1.09M Buy
+16,196
New +$1.01M 1.01% 39
2018
Q3 		– Sell
-18,240
Closed -$291 – 73
2018
Q2 		$291 Buy
+18,240
New +$387K 0.27% 60

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Altman Advisors's DXCM Position: Q2 2024 in Review

Altman Advisors sold out of DexCom (DXCM) in Q2 2024, closing a stake of 13,950 shares — an estimated $1.92M sold.

Altman Advisors first reported a position in DXCM in Q2 2018 and held it in 17 quarters. The position peaked at $3.38M in Q3 2021. 999 funds tracked by Wall St. Rank hold DXCM as of Q2 2024.

  • Altman Advisors reported no remaining DexCom position as of Q2 2024 after selling out during the quarter.
  • Altman Advisors sold 13,950 DexCom shares in Q2 2024, an estimated $1.92M.
  • Altman Advisors first reported a position in DexCom in Q2 2018 and held it in 17 quarters.
  • Altman Advisors's DexCom position peaked at $3.38M in Q3 2021.
  • 999 funds tracked by Wall St. Rank held DexCom as of Q2 2024.

Based on Altman Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.